Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Medicamen Biotech Limited
Medicamen Biotech Limited, with incorporation dating back to 1993, brings more than 3 decades of expertise. Medicamen Biotech Limited holds the CIN L74899DL1993PLC056594 and registration number 56594. It falls under the category of company limited by shares. Its authorized capital has been set at ₹15.00 crore. Paid-up capital for the company equals ₹12.71 crore.
The firm focuses on other business activities. Medicamen Biotech Limited is officially registered in Delhi. Its registered address is 1506, Chiranjiv Tower, 43, Nehru Place, South Delhi, New Delhi, Delhi, India, 110019. Its current corporate status is active. Medicamen Biotech Limited holds PAN AAACM1217A. The Legal Entity Identifier assigned to the company is 894500T0ULD27B7W4Y03. You can reach the company via email at cs@medicamen.com. The company is led by Rajesh Madan (CEO).
Company Overview
- CIN
- Date of Incorporation
- 21/12/1993
- Company Status
- Active
- RoC
- Delhi
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹15,00,00,000.00
- Paid up Capital
- ₹12,71,46,000.00
- Activity
- OTHER BUSINESS ACTIVITIES
- cs@medicamen.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Delhi | 07AAACM1217A2ZA | Active |
| 07AAACM1217A1ZB | Active | |
| Rajasthan | 08AAACM1217A1Z9 | Active |
| Uttarakhand | 05AAACM1217A1ZF | Active |
| 05AAACM1217A2ZE | Active | |
| Uttar Pradesh | 09AAACM1217A1Z7 | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE646B13031 | MEDICAMEN BIOTECH LIMITED WARRANTS 24OT26 | - | 24/10/2026 | MEDICAMEN BIOTE/WT 20261024 | RWSTCA |
| INE646B01010 | MEDICAMEN BIOTECH LIMITED EQ | - | 12/10/2026 | MEDICAMEN BIOTE/SH VTG | ESVUFN |
| IN8646B01019 | MEDICAMEN BIOTECH LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | MEDICAMEN BIOTE/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2020 | 31/03/2019 | 31/03/2018 | 31/03/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net PPE | ₹8,409.21L | ₹8,636.22L | ₹9,095.18L | ₹9,175.88L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Debt | ₹1,651.94L | ₹3,001.48L | ₹1,632.59L | ₹493.01L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross PPE | ₹8,409.21L | ₹13,702.99L | ₹13,495.68L | ₹12,885.57L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Inventory | ₹7,007.95L | ₹6,213.74L | ₹5,937.52L | ₹4,505.73L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹4,778.36L | ₹3,377.42L | ₹3,111.15L | ₹2,570.90L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock | ₹1,356.28L | ₹1,271.46L | ₹1,271.46L | ₹1,265.11L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt | ₹4,163.10L | ₹3,003.99L | ₹2,985.60L | ₹2,483.94L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Share Issued | ₹135.63L | ₹127.15L | ₹127.15L | ₹126.51L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Assets | ₹37,198.84L | ₹29,715.05L | ₹29,455.10L | ₹27,851.73L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Capital Stock | ₹1,356.28L | ₹1,271.46L | ₹1,271.46L | ₹1,265.11L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Debt | ₹615.26L | ₹373.43L | ₹125.55L | ₹86.96L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹22,373.41L | ₹16,454.93L | ₹15,959.37L | ₹16,336.27L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Working Capital | ₹13,581.45L | ₹8,638.75L | ₹7,503.83L | ₹8,078.92L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Invested Capital | ₹32,333.36L | ₹24,562.93L | ₹23,620.44L | ₹21,912.31L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Properties | ₹8,409.21L | ₹1,961.02L | ₹1,927.36L | ₹1,733.09L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock Equity | ₹27,555.00L | ₹21,185.51L | ₹20,509.29L | ₹19,341.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Tangible Assets | ₹27,497.84L | ₹21,111.28L | ₹20,419.46L | ₹19,251.64L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tangible Book Value | ₹27,497.84L | ₹21,111.28L | ₹20,419.46L | ₹19,251.64L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹8,791.96L | ₹7,816.18L | ₹8,455.54L | ₹8,257.35L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Provisions | ₹236.62L | ₹220.44L | ₹175.58L | ₹166.01L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Stockholders Equity | ₹27,555.00L | ₹21,185.51L | ₹20,509.29L | ₹19,341.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Equity Interest | ₹26,198.72L | ₹20,006.63L | ₹18,777.11L | ₹260.55L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Capitalization | ₹28,170.26L | ₹21,558.94L | ₹20,634.84L | ₹19,428.37L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹135.63L | ₹127.15L | ₹127.15L | ₹126.51L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Intangible Assets | ₹57.16L | ₹74.23L | ₹89.83L | ₹89.77L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | ₹5,546.50L | ₹4,142.20L | ₹3,937.33L | ₹1,951.20L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Non Current Assets | ₹14,825.43L | ₹13,260.11L | ₹13,495.73L | ₹11,515.46L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹3,126.42L | ₹375.94L | ₹1,478.56L | ₹2,077.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹57.16L | ₹74.23L | ₹89.83L | ₹89.77L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹27,555.00L | ₹21,305.30L | ₹20,698.44L | ₹19,341.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹9,643.84L | ₹8,409.75L | ₹8,756.66L | ₹8,510.32L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹4,163.10L | ₹3,003.99L | ₹2,985.60L | ₹2,483.94L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹615.26L | ₹373.43L | ₹125.55L | ₹86.96L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹3,126.42L | ₹375.94L | ₹1,478.56L | ₹2,077.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹851.88L | ₹593.57L | ₹301.12L | ₹252.97L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2020 | 31/03/2019 | 31/03/2018 | 31/03/2017 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -₹3,795.01L | -₹1,034.73L | -₹1,303.10L | -₹1,289.39L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Changes In Cash | ₹2,750.48L | -₹1,102.62L | -₹599.32L | ₹1,695.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| End Cash Position | ₹3,126.42L | ₹375.94L | ₹1,478.56L | ₹2,077.88L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Financing Cash Flow | ₹6,371.58L | -₹147.06L | ₹631.35L | ₹2,912.73L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Investing Cash Flow | -₹303.87L | -₹139.68L | -₹556.29L | -₹588.04L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Cash Flow | -₹3,317.23L | -₹815.88L | -₹674.38L | -₹629.28L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Capital Expenditure | -₹477.78L | -₹218.85L | -₹628.72L | -₹660.11L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Beginning Cash Position | ₹375.94L | ₹1,478.56L | ₹2,077.88L | ₹382.48L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Issuance Of Capital Stock | ₹5,356.79L | ₹0.00L | ₹189.66L | ₹3,341.16L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2020 | 31/03/2019 | 31/03/2018 | 31/03/2017 |
|---|---|---|---|---|---|---|---|---|---|
| EBIT | ₹1,548.18L | ₹1,303.61L | ₹1,747.28L | ₹1,996.77L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹2,270.03L | ₹2,010.22L | ₹2,456.60L | ₹2,633.43L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹964.13L | ₹710.82L | ₹1,093.10L | ₹1,484.41L | ₹0.00L | ₹1,225.89L | ₹1,221.49L | ₹1,011.27L | ₹516.01L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹9,599.78L | ₹7,792.92L | ₹6,975.78L | ₹5,487.59L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Pretax Income | ₹1,198.44L | ₹988.00L | ₹1,307.56L | ₹1,704.50L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Provision | ₹218.80L | ₹332.43L | ₹358.16L | ₹231.65L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹19,776.97L | ₹16,254.72L | ₹17,930.62L | ₹14,086.74L | ₹0.00L | ₹11,734.23L | ₹12,260.45L | ₹11,150.72L | ₹8,276.23L |
| Cost Of Revenue | ₹10,177.19L | ₹8,461.80L | ₹10,954.84L | ₹8,599.15L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Expenses | ₹18,540.10L | ₹15,575.50L | ₹16,190.20L | ₹12,197.79L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹349.74L | ₹315.61L | ₹439.72L | ₹292.27L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Income | ₹1,236.87L | ₹679.22L | ₹1,740.42L | ₹1,888.95L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹2,270.03L | ₹2,010.22L | ₹2,547.52L | ₹2,723.25L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized Income | ₹964.13L | ₹710.82L | ₹1,159.12L | ₹1,562.02L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Expense | ₹8,362.91L | ₹7,113.70L | ₹5,235.36L | ₹3,598.64L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Revenue | ₹19,776.97L | ₹16,254.72L | ₹17,930.62L | ₹14,086.74L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Interest Income | -₹349.74L | -₹315.61L | -₹494.75L | -₹267.12L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹0.00L | -₹90.92L | -₹89.82L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹135.63L | ₹127.15L | ₹126.59L | ₹126.51L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Diluted Average Shares | ₹135.63L | ₹127.15L | ₹126.59L | ₹126.51L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Operating Expenses | ₹4,171.75L | ₹3,219.80L | ₹41.07L | ₹29.67L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Depreciation | ₹721.85L | ₹691.01L | ₹709.32L | ₹636.66L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹10,177.19L | ₹8,461.80L | ₹10,954.84L | ₹8,599.15L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | -₹24.90L | -₹12.21L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹349.74L | ₹315.61L | ₹439.72L | ₹292.27L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Common Stockholders | ₹964.13L | ₹710.82L | ₹1,093.10L | ₹1,484.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Continuous Operations | ₹979.64L | ₹655.57L | ₹949.40L | ₹1,472.85L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹964.13L | ₹710.82L | ₹1,093.10L | ₹1,484.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | -₹90.92L | -₹89.82L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹349.74L | -₹315.61L | -₹494.75L | -₹267.12L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹979.64L | ₹655.57L | ₹949.40L | ₹1,472.85L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹964.13L | ₹710.82L | ₹1,093.10L | ₹1,484.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹964.13L | ₹710.82L | ₹1,093.10L | ₹1,484.41L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Company Performance (FY17–FY26)
₹197.8 Cr₹148.3 Cr₹98.9 Cr₹49.4 Cr₹0
FY17FY18FY19FY20FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 31/12/2015 | Suresh Kumar Singh | 00318015 | Director | View other directorships |
| 31/12/2015 | Ashwani Kumar Sharma | 00325634 | Director | View other directorships |
| 31/12/2015 | Harish Pande | 01575625 | Director | View other directorships |
| 31/12/2015 | Rahul Bishnoi | 00317960 | Director | View other directorships |
| 27/02/2016 | Sanjay Bansal | 00121667 | Director | View other directorships |
| 27/02/2016 | Arun Kumar | 07031730 | Director | View other directorships |
| 30/05/2016 | Rajesh Madan | *****5543J | CEO | |
| 12/02/2018 | Parul Choudhary | *****3464Q | Company Secretary | |
| 13/11/2018 | Sumita Dwivedi | 08218640 | Director | View other directorships |
| 11/02/2019 | Vimal Kumar Shrawat | 08274190 | Director | View other directorships |
| 11/02/2019 | Sangeeta Bishnoi | 08288998 | Director | View other directorships |
| 30/05/2019 | Ravi Kumar Bansal | 08462513 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 12
- Ravi Kumar BansalDirector
- Sangeeta BishnoiDirector
- Vimal Kumar ShrawatDirector
- Sumita DwivediDirector
- Arun KumarDirector
- Sanjay BansalDirector
- Ashwani Kumar SharmaDirector
- Harish PandeDirector
- Rahul BishnoiDirector
- Suresh Kumar SinghDirector
- Parul ChoudharyCompany Secretary
- Rajesh MadanCEO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 16/11/2024 | Form MGT-7-16112024_signed | - |
| 07/11/2024 | Form AOC-4(XBRL)-25102024 | - |
| 30/03/2024 | Form Addendum to AOC-4 CSR-30032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Alirox Abrasives Limited | L74899DL1944PLC000759 | 4 Scindia House, Central Delhi, New Delhi, Delhi, India, 110001 |
| Dcm Limited | L74899DL1889PLC000004 | Unit Nos. 2050 To 2052, 2nd Floor,plaza Square,20, Manohar Lal Khurana Marg,bara, Hindu Rao, Delhi, Delhi, India, 110006 |
| Moradabad Syntex Limited | L74899DL1907PLC006509 | Flat No.2; E 55; Krishna Park; Devli Road; Khanpur; New Delhi.; Delhi; 110062; India |
| The Delhi Safe Deposit Company Limited | L74899DL1937PLC000478 | 86janpath, New Delhi, Delhi, India, 000000 |
| The Motor And General Finance Limited | L74899DL1930PLC000208 | Mgf House 4/17-basaf Ali Road, New Delhi, Delhi, India, 110002 |
Address
1506, Chiranjiv Tower, 43, Nehru Place, South Delhi, New Delhi, Delhi, India, 110019
Frequently Asked Questions
What is the incorporation date of Medicamen Biotech Limited?
The incorporation date of Medicamen Biotech Limited is 21/12/1993.
What is the authorized share capital and paid-up capital of Medicamen Biotech Limited?
The authorized share capital of Medicamen Biotech Limited is ₹15,00,00,000.00. The paid-up capital is ₹12,71,46,000.00.
Who are the current board members & directors of Medicamen Biotech Limited?
The current board member of Medicamen Biotech Limited are:
- Sumita Dwivedi
- Suresh Kumar Singh
- Vimal Kumar Shrawat
- Sangeeta Bishnoi
- Ravi Kumar Bansal
- Sanjay Bansal
- Ashwani Kumar Sharma
- Harish Pande
- Rahul Bishnoi
- Arun Kumar
What is the registered address of Medicamen Biotech Limited?
The registered address of Medicamen Biotech Limited is 1506, Chiranjiv Tower, 43, Nehru Place, South Delhi, New Delhi, Delhi, India, 110019.
What is the Corporate Identification Number of Medicamen Biotech Limited?
The Corporate Identification Number of Medicamen Biotech Limited is L74899DL1993PLC056594.